Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Secondary prophylaxis after ischemic stroke and transitoric ischemic attack].

David Russell1, Christian Lund, Arve Dahl

  • 1Cerebrovaskulaer seksjon, Nevrologisk avdeling, Nevroklinikken, Rikshospitalet-Radiumhospitalet, 0027 Oslo. david.russell@medisin.uio.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|May 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.

Advances in therapy·2026
Same author

Family perspective: raising a child with NEC and the need for multidisciplinary care.

World journal of pediatric surgery·2026
Same author

Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.

Advances in therapy·2026
Same author

Developing and validating a sequence-aware deep learning model for infection risk prediction in home care.

International journal of medical informatics·2026
Same author

Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Overexpression of thioredoxin-1 enhances angiogenesis and survival in a mouse ischemic skin flap model.

Surgery·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Secondary prevention after ischemic stroke or TIA is crucial. Optimal blood pressure, blood glucose, antithrombotic, and lipid-lowering therapies can prevent cerebrovascular events and death.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Public Health

Context:

  • Stroke affects approximately 13,000 individuals annually in Norway, with 3,000 experiencing recurrent strokes.
  • Over 10,000 patients annually suffer transient ischemic attacks (TIAs), which often precede strokes.
  • High incidence of stroke and TIA necessitates updated secondary prevention strategies.

Purpose:

  • To present updated treatment recommendations for secondary prophylaxis after ischemic stroke or TIA.
  • To provide evidence-based guidelines for preventing recurrent cerebrovascular events.
  • To adapt international guidelines for Norwegian clinical practice.

Summary:

  • Individualised secondary prophylaxis is key to preventing cerebrovascular disease and mortality.

Related Experiment Videos

  • Optimal management includes controlling blood pressure and blood glucose levels.
  • Adequate antithrombotic and lipid-lowering treatments are essential components of secondary prevention.

    • Impact:

    • Implementation of these recommendations can significantly reduce stroke recurrence and associated mortality.
    • Improved patient outcomes through tailored secondary prevention strategies.
    • Enhanced public health by mitigating the burden of cerebrovascular diseases.